Exscientia plc

NASDAQ:EXAI

4.9 (USD) • At close September 6, 2024
Bedrijfsnaam Exscientia plc
Symbool EXAI
Munteenheid USD
Prijs 4.9
Beurswaarde 622,386,779
Dividendpercentage 0%
52-weken bereik 3.8 - 7.91
Industrie Biotechnology
Sector Healthcare
CEO Prof. Andrew L. Hopkins DPHIL, FMEDSCI, FRSE FRSC
Website https://www.exscientia.ai

An error occurred while fetching data.

Over Exscientia plc

Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to

Vergelijkbare Aandelen

Cytek Biosciences, Inc. logo

Cytek Biosciences, Inc.

CTKB

5.3 USD

Prothena Corporation plc logo

Prothena Corporation plc

PRTA

20.33 USD

Veracyte, Inc. logo

Veracyte, Inc.

VCYT

28.57 USD

NextGen Healthcare, Inc. logo

NextGen Healthcare, Inc.

NXGN

23.94 USD

Clover Health Investments, Corp. logo

Clover Health Investments, Corp.

CLOV

2.51 USD

Pacific Biosciences of California, Inc. logo

Pacific Biosciences of California, Inc.

PACB

1.58 USD

P3 Health Partners Inc. logo

P3 Health Partners Inc.

PIII

0.46 USD

Celldex Therapeutics, Inc. logo

Celldex Therapeutics, Inc.

CLDX

43.76 USD

CareDx, Inc logo

CareDx, Inc

CDNA

27.1 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)